MedTrace Logo

Effect of Stevia Leave Powder on Blood Glucose and Lipid Profile of Diabetic Patients

NCT06645002 · Status: ENROLLING_BY_INVITATION · Phase: NA · Type: INTERVENTIONAL · Enrollment: 144

Last updated 2024-10-16

No results posted yet for this study

Summary

The goal of this clinical trial is to know if stevia leave powder capsule (1000 mg/day) will work to treat diabetes in participants. The main objectives it aims to answer are:

Does stevia decrease the blood glucose level in diabetic subjects that will use stevia powder capsule? Does stevia play its role in blood lipid profile in diabetic subjects that will use stevia powder capsule? The purpose of the study to see the impact of stevia in short (7 days) and long-term treatments (60 days) in diabetic subjects and compare the results

Diabetic subjects will:

Take stevia powder capsule every day for 7 days in short term study Take stevia powder capsule every day for 60 days in long term study

Check the biochemical assessment including blood glucose and lipid profile tests at 0 and 7th days in short term study Check the biochemical assessment including blood glucose and lipid profile tests at 0 and 30 and 60th days in long term study Keep a record of all the tests for comparison

Conditions

Interventions

DIETARY_SUPPLEMENT

stevia rebaudiana bertoni

effect of short term study (7 days) of stevia leave powder 1000 mg/day in diabetic subjects

DIETARY_SUPPLEMENT

stevia rebaudiana bertoni

effect of long term study (60 days) of stevia leave powder 1000 mg/day in diabetic subjects

Sponsors & Collaborators

  • Allied Hospital Faisalabad

    collaborator OTHER

  • University of Lahore

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
25 Years
Max Age
35 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-08-22
Primary Completion
2024-11-22
Completion
2025-02-22

Countries

  • Pakistan

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06645002 on ClinicalTrials.gov